You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA-lncRNA signature

Showing 1 - 25 of 1,460
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Breast Cancer Trial in Shanghai (docetaxel, doxorubicin or epirubicin, cyclophosphamide)

Unknown status
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 22, 2020

Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25

Recruiting
  • Glioblastoma
  • CV09050101 mRNA vaccine (CVGBM) 12 μg
  • +5 more
  • Woluwe-Saint-Lambert, Brussels, Belgium
  • +14 more
Jul 12, 2023

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Blood sample collection
  • Mansoura, Dakahliya, Egypt
  • +1 more
Apr 5, 2022

Cancer Trial in Anderlecht (Spikevax, Comirnaty)

Recruiting
  • Cancer
  • Spikevax
  • Comirnaty
  • Anderlecht, Belgium
  • +1 more
Aug 30, 2022

Hepatocellular Carcinoma, Desflurane Adverse Reaction, Propofol Adverse Reaction Trial in Hangzhou (Des?urane, Propofol)

Completed
  • Hepatocellular Carcinoma
  • +3 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer hospital
Aug 15, 2022

Genomics Research Based on Ultrasound Endoscopic Biopsy in

Recruiting
  • Pancreatic Space Occupying
    • Shanghai, Shanghai, China
      Shanghai Changhai Hospital
    Jul 29, 2021

    CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

    Recruiting
    • CNS Tumor
    • Solid Tumor
    • Nivolumab and Entinostat
    • Randwick, New South Wales, Australia
    • +13 more
    Nov 8, 2022

    Chronicization of Radiation-induced Acute Intestinal Injury

    Not yet recruiting
    • Radiation-induced Intestinal Injury
    • NCRT+TME
    • (no location specified)
    Feb 19, 2023

    Advanced Gastric Carcinoma, Immunotherapy Trial in Beijing (Circulating exosomal lncRNA-GC1 detection)

    Completed
    • Advanced Gastric Carcinoma
    • Immunotherapy
    • Circulating exosomal lncRNA-GC1 detection
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Oct 7, 2022

    Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

    Not yet recruiting
    • HCC
    • No intervention was required for patients or control group in this study
    • (no location specified)
    Apr 21, 2023

    lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially

    Completed
    • Potentially Malignant Lesions, Oral Lichen Planus, Leukoplakia
    • Real-time Polymerase Chain Reaction technique
    • Fayoum, Egypt
      Fayoum University
    Feb 7, 2023

    Systemic Lupus Erythematosus, Interferon Deficiency Trial in Copenhagen (High Intensity Interval Training)

    Recruiting
    • Systemic Lupus Erythematosus
    • Interferon Deficiency
    • High Intensity Interval Training
    • Copenhagen, Denmark
      Center for Physical Activity Research
    Jul 26, 2022

    Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients

    Recruiting
    • Gastric Cancer
    • Chemotherapy Effect
    • Detection of levels of circulating EV-derived lncRNA-GC1
    • Beijing, Beijing, China
      Chinese PLA General Hospital Ethics Committee
    Dec 12, 2022

    SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273.211
    • +6 more
    • Sacramento, California
    • +22 more
    Nov 16, 2022

    Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)

    Recruiting
    • Seasonal Influenza
    • mRNA-1011.1
    • +5 more
    • Lakewood, California
    • +21 more
    Apr 12, 2023

    Acute Stroke, Ischemic Stroke Trial in Nanjing (Sequencing of circRNA/miRNA/lncRNA)

    Recruiting
    • Acute Stroke
    • Ischemic Stroke
    • Sequencing of circRNA/miRNA/lncRNA
    • Nanjing, Jiangsu, China
      Nanjing First Hospital, Nanjing Medical University
    Apr 5, 2022

    SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)

    Recruiting
    • SARS-CoV-2
    • +2 more
    • mRNA-1010
    • +4 more
    • DeLand, Florida
    • +29 more
    Jan 23, 2023

    Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)

    Recruiting
    • Respiratory Syncytial Virus
    • Human Metapneumovirus
    • mRNA-1345
    • +3 more
    • Andalusia, Alabama
    • +72 more
    Feb 15, 2023

    Mixed Molecular Clinical Index in Diffuse Large B-cell Lymphoma

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • molecular characterization
    • Meldola, FC, Italy
    • +3 more
    Feb 25, 2021

    Influenza Immunization Trial in Australia (H3 mRNA / LNP Vaccine, Quadrivalent recombinant influenza Vaccine (RIV4))

    Recruiting
    • Influenza Immunization
    • H3 mRNA / LNP Vaccine
    • Quadrivalent recombinant influenza Vaccine (RIV4)
    • Herston, Queensland, Australia
    • +3 more
    May 1, 2023

    Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)

    Recruiting
    • Lyme Disease
    • mRNA-1975
    • +2 more
    • Milford, Connecticut
    • +19 more
    Jul 26, 2023

    Innate Immunity in Allergic Asthma

    Recruiting
    • Asthma
      • Orlando, Florida
        University of Central Florida
      Sep 28, 2023

      Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

      Not yet recruiting
      • Norovirus Acute Gastroenteritis
      • mRNA-1403
      • +2 more
      • Long Beach, California
      • +14 more
      Aug 7, 2023

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Seasonal Influenza Trial in United States (mRNA-1030, mRNA-1020, mRNA-1010)

      Completed
      • Seasonal Influenza
      • mRNA-1030
      • +3 more
      • Phoenix, Arizona
      • +14 more
      Dec 5, 2022